Each state, U.S. territory, and the District of Columbia must ...

[saraeharris]

Each state, U.S. territory, and the District of Columbia must have a quality improvement organization (QIO) contracted with CMS to provide support and oversight to LTC facilities.
 
  Which of the following are functions of quality improvement organizations? Select all answers that apply. A) Staff development
  B) Monitoring techniques and intervention strategies
  C) Quality improvement for facility manager
  D) Training nonlicensed personnel
  E) Informing clients of their rights
  F) Providing advance degree nursing courses

Question 2

The nurse is about to administer a Category C drug to a pregnant client. Which of the following describes this FDA category of risk potential during pregnancy?
 
  A) A risk has not been documented during pregnancy.
  B) Animal studies show no risk, but there is inadequate documentation in humans.
  C) Animal studies show adverse affects but there are no adequate studies in humans.
  D) There is evidence of human fetal risk, but the benefits may outweigh risks.

[connor417]

Answer to Question 1

A, B, C, D
Feedback:
Functions of QIOs include the following: providing educational materials and resources to facilities for staff development, guidance for quality improvement for facility managers and staff (to improve care), monitoring techniques and intervention strategies to improve care, and giving recommendations for training and/or certification of nonlicensed personnel.

Answer to Question 2

C
Feedback:
The following are FDA pregnancy categories: Category A: A risk has not been documented during pregnancy. Category B: Animal studies have not shown a risk, but there is inadequate documentation in humans, OR animal studies have shown adverse effects, but this has not been demonstrated in humans. Category C: Animal studies have shown adverse effects, but there are no adequate studies in humans, OR the benefits to the pregnant woman may outweigh potential risks, OR there are no adequate studies in humans or animals. Category D: There is evidence of human fetal risk, but the benefits may outweigh potential risks. Category X: Abnormalities have been documented the risk of use in pregnant women precludes the use of this medication.